Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liaoning Hisun Pharmaceutical is a significant manufacturing subsidiary of Zhejiang Hisun Pharmaceutical, located in Huludao, China. Established to expand the parent company's production capacity, the facility specializes in the large-scale manufacture of active pharmaceutical ingredients (APIs) and finished drug products. The site is particularly noted for its advanced fermentation and chemical synthesis capabilities, producing a wide range of therapies including anti-infectives, cardiovascular agents, and oncology treatments. Liaoning Hisun operates under strict international GMP standards, enabling it to supply high-quality pharmaceuticals to both the Chinese domestic market and highly regulated global markets like the US and EU. As a core component of Hisun's industrial chain, the company plays a vital role in the group's vertical integration and global competitiveness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liaoning Hisun Pharmaceutical.